The medical biology laboratory market in Spain

The global market for medical laboratories is set to grow to around $303.1 billion by 2026, with an average annual growth rate of 5.1%. Italy plays an important role in this sector, employing around 33,000 people and showing a clear preference for accredited laboratories, which boast higher rates of sales growth and efficiency. The COVID-19 pandemic has underlined the critical importance of this industry, as laboratories such as Italy's Copan have seen their revenues increase dramatically (415 million euros in 2020) due to the explosion in demand for testing supplies such as flocked swabs. Demographic factors, in particular the ageing population and income levels, are significantly boosting demand for laboratory services in Italy. Geographically, there is a concentration of public laboratories in the northern regions, while private laboratories dominate the southern regions, with Campania leading the way in terms of total number of laboratories. The sector saw a sharp 8.8% increase in

The Spanish medical equipment market has shown significant growth and development between 2020 and 2022. Exports of medical equipment slightly increased by 8.1% to $762 million in 2022, while imports saw a more substantial rise of 38.5%, reaching $3060 million, leading to a growing trade deficit. The United States remained the leading source of imports, whereas Portugal was the top destination for Spain's exports. The domestic market also expanded, with sales in the radiation, electromedical, and electrotherapeutic equipment manufacturing sector growing by 41.8% to €428.250 million. Additionally, the medical and dental instruments and supplies sector saw a 15.1% increase in sales. Employment in the industry rose in both sectors, suggesting sector consolidation and expansion. Overall, the European medical equipment market, where Spain is a player, is growing steadily, with an annual rate of 4.8%, reaching a value of €150 billion in 2021. The Spanish healthcare system's expenditure climb

The French medical biology market is worth over €5 billion. In 2020 , the market for medical biology laboratories boomed as a result of the COVID-19 pandemic, leading to a significant increase in demand for PCR tests and antigens. Between May 2020 and the end of 2022, laboratories performed around 120 million Covid PCR tests, contributing around 25% of their sales. Sales are down on the peak years of the pandemic, but remain well above pre-pandemic baseline levels. The market is undergoing major restructuring, with a considerable reduction in the number of laboratories as a result of mergers and acquisitions. 4,200 biology sites are controlled by 400 laboratories in France, the number of which has been divided by 10 in a decade . Although the number of laboratories has fallen, employment has remained relatively stable. The market is mainly operated by large groups such as Biogroup, Cerba and Inovie, which have a combined market share of 40%. Despite market consolidation, independent la